Sean T Allen1, Rebecca Hamilton White2, Allison O'Rourke3, Suzanne M Grieb4, Michael E Kilkenny5, Susan G Sherman6. 1. Department of Health, Behavior and Society, Johns Hopkins Bloomberg School of Public Health, 624 N. Broadway, Baltimore, MD, 21205, USA. Electronic address: sallen63@jhu.edu. 2. Department of Health, Behavior and Society, Johns Hopkins Bloomberg School of Public Health, 624 N. Broadway, Baltimore, MD, 21205, USA. Electronic address: rwhite75@jhmi.edu. 3. DC Center for AIDS Research, Department of Psychology, George Washington University, 2125 G St. NW, Washington, DC, 20052, USA. Electronic address: orourkea@gwu.edu. 4. Center for Child and Community Health Research, Department of Pediatrics, Johns Hopkins School of Medicine, Baltimore, MD, 21224, USA. Electronic address: sgrieb1@jhmi.edu. 5. Cabell-Huntington Health Department, 703 7th Ave., Huntington, WV, 25701, USA. Electronic address: Michael.E.Kilkenny@wv.gov. 6. Department of Health, Behavior and Society, Johns Hopkins Bloomberg School of Public Health, 624 N. Broadway, Baltimore, MD, 21205, USA. Electronic address: ssherman@jhu.edu.
Abstract
BACKGROUND: Take-home naloxone (THN) possession among people who inject drugs (PWID) in rural communities is understudied. Better understanding the nature of THN possession among rural PWID could inform the implementation of overdose prevention initiatives. The purpose of this research is to determine factors associated with rural PWID having recently received THN. METHODS: Data from a PWID population estimation study implemented in Cabell County, West Virginia were used for this research. Multivariable Poisson regression with a robust variance estimator was used to evaluate the independent effects of several measures (e.g., sociodemographics, structural vulnerabilities, substance use) on PWID having received THN in the past 6 months. RESULTS: Forty-eight percent of our sample (n = 371) of PWID reported having received THN in the past 6 months. Factors associated with having received THN were: age (adjusted Prevalence Ratio [aPR] = 1.02; 95% Confidence Interval [CI]: 1.01-1.03), having recently accessed sterile syringes at a needle exchange program (aPR = 1.82; 95% CI: 1.35-2.46), believing that doctors judge people who use drugs (aPR = 1.50; 95% CI: 1.07-2.12), and having witnessed at least one non-fatal overdose in the past 6 months (aPR = 1.44; 95% CI: 1.06-1.94). Greater numbers of overdose events in the past 6 months were also associated with having received THN. CONCLUSIONS: Among rural PWID in West Virginia, slightly less than half received THN in the past 6 months. Rural communities need overdose prevention interventions that are responsive to the unique needs of rural PWID, decrease stigma, and ensure PWID have access to harm reduction services and drug treatment programs.
BACKGROUND: Take-home naloxone (THN) possession among people who inject drugs (PWID) in rural communities is understudied. Better understanding the nature of THN possession among rural PWID could inform the implementation of overdose prevention initiatives. The purpose of this research is to determine factors associated with rural PWID having recently received THN. METHODS: Data from a PWID population estimation study implemented in Cabell County, West Virginia were used for this research. Multivariable Poisson regression with a robust variance estimator was used to evaluate the independent effects of several measures (e.g., sociodemographics, structural vulnerabilities, substance use) on PWID having received THN in the past 6 months. RESULTS: Forty-eight percent of our sample (n = 371) of PWID reported having received THN in the past 6 months. Factors associated with having received THN were: age (adjusted Prevalence Ratio [aPR] = 1.02; 95% Confidence Interval [CI]: 1.01-1.03), having recently accessed sterile syringes at a needle exchange program (aPR = 1.82; 95% CI: 1.35-2.46), believing that doctors judge people who use drugs (aPR = 1.50; 95% CI: 1.07-2.12), and having witnessed at least one non-fatal overdose in the past 6 months (aPR = 1.44; 95% CI: 1.06-1.94). Greater numbers of overdose events in the past 6 months were also associated with having received THN. CONCLUSIONS: Among rural PWID in West Virginia, slightly less than half received THN in the past 6 months. Rural communities need overdose prevention interventions that are responsive to the unique needs of rural PWID, decrease stigma, and ensure PWID have access to harm reduction services and drug treatment programs.
Authors: Mark Faul; Michael W Dailey; David E Sugerman; Scott M Sasser; Benjamin Levy; Len J Paulozzi Journal: Am J Public Health Date: 2015-04-23 Impact factor: 9.308
Authors: Christopher Rowe; Glenn-Milo Santos; Eric Vittinghoff; Eliza Wheeler; Peter Davidson; Philip O Coffin Journal: Addiction Date: 2015-08 Impact factor: 6.526
Authors: Traci C Green; Lauretta E Grau; Ksenia N Blinnikova; Mikhail Torban; Evgeny Krupitsky; Ruslan Ilyuk; Andrei Kozlov; Robert Heimer Journal: Int J Drug Policy Date: 2008-09-05
Authors: Sean T Allen; Suzanne M Grieb; Allison O'Rourke; Ryan Yoder; Elise Planchet; Rebecca Hamilton White; Susan G Sherman Journal: Harm Reduct J Date: 2019-05-21
Authors: Sean T Allen; Suzanne M Grieb; Rebecca Hamilton White; Allison O'Rourke; Michael E Kilkenny; Christopher M Jones; Carl Latkin; Susan G Sherman Journal: J Infect Dis Date: 2020-09-02 Impact factor: 5.226
Authors: N Jia Ahmad; Sean T Allen; Rebecca Hamilton White; Kristin E Schneider; Allison O'Rourke; Michelle Perdue; Charles Babcock; Michael E Kilkenny; Susan G Sherman Journal: Harm Reduct J Date: 2021-02-18
Authors: Kristin E Schneider; Rebecca Hamilton White; Allison O'Rourke; Michael E Kilkenny; Michelle Perdue; Susan G Sherman; Suzanne M Grieb; Sean T Allen Journal: AIDS Care Date: 2020-09-21